Venture Map · Round
MiMARK Diagnostics — Other · €1.5M
Announced 2021-02-11 · Barcelona · Diagnostics / women's health
MiMARK, a spin-off from Vall d'Hebron developing in vitro diagnostics for endometrial cancer, won €1.5M through EIT Health's Wild Card programme. This is programme funding rather than a priced venture round.
RoundOther
Amount€1.5M
LeadEIT Health
Date2021-02-11
CityBarcelona
SectorDiagnostics / women's health
The company
Investors 1
EEIT Health